Venocentric lesions: An MRI marker of MS?

Frontiers in Neurology

Volumn 4 JUL, Issue , 2013, Pages

  Quinn, Matthew P ^a,b   Kremenchutzky, Marcelo ^c   Menon, Ravi S ^a,b  

^a WESTERN UNIVERSITY   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Magnetic resonance imaging; Multiple sclerosis; Susceptibility weighted imaging; T2z.ast; ; Venocentric lesions; Weighted imaging

Indexed keywords

GADOLINIUM;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ARTICLE; CENTRAL VEIN; CEREBROSPINAL FLUID ANALYSIS; DEMYELINATION; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; EVOKED VISUAL RESPONSE; HUMAN; IRON STORAGE; MICROANGIOPATHY; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SUSAC SYNDROME; SUSCEPTIBILITY WEIGHTED IMAGING; VENOCENTRIC LESION; WHITE MATTER; WHITE MATTER LESION;

EID: 84883549223     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00098     Document Type: Article

References (33)

1. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol (2011) 69:292-302. doi:10.1002/ana.22366
2. Eckstein C, Saidha S, Levy M. A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis. J Neurol (2012) 259:801-16. doi:10.1007/s00415-011-6240-5
3. Charil A, Yousry TA, Rovaris M, Barkhof F, De Stefano N, Fazekas F, et al. Mri and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". Lancet Neurol (2006) 5:841-52. doi:10.1016/S1474-4422(06)70572-5
4. Bergamaschi R, Quaglini S, Tavazzi E, Amato MP, Paolicelli D, Zipoli V, et al. Immunomodulatory therapies delay disease progression in multiple sclerosis. Mult Scler (2012): doi:10.1177/1352458512445941
5. Charcot JM. Histologie de la sclèrose en plaque. Gaz Hop (1868) 41:554-5.
6. Tan IL, van Schijndel RA, Pouwels PJ, van Walderveen MA, Reichenbach JR, Manoliu RA, et al. MR venography of multiple sclerosis. AJNR Am J Neuroradiol (2000) 21:1039-42.
7. Mistry N, Dixon J, Tallantyre E, Tench C, Abdel-Fahim R, Jaspan T, et al. Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain. JAMA Neurol (2013) 70:623-8. doi:10.1001/jamaneurol.2013.1405
8. Dawson JD. The histology of disseminated sclerosis. Trans R Soc Edinb (1916) 50:517-740. doi:10.1017/S0080456800027174
9. Adams CW. Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry (1988) 51:260-5. doi:10.1136/jnnp.51.2.260
10. Callen DJ, Shroff MM, Branson HM, Li DK, Lotze T, Stephens D, et al. Role of MRI in the differentiation of ADEM from MS in children. Neurology (2009) 72:968-73. doi:10.1212/01.wnl.0000338630.20412.45
11. Young NP, Weinshenker BG, Parisi JE, Scheithauer B, Giannini C, Roemer SF, et al. Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain (2010) 133:333-48. doi:10.1093/brain/awp321
12. van Bogaert L. Post-infectious encephalomyelitis and multiple sclerosis; the significance of perivenous encephalomyelitis. J Neuropathol Exp Neurol (1950) 9:219-49. doi:10.1097/00005072-195007000-00001
13. Oh J, Levy M. Neuromyelitis optica: an antibody-mediated disorder of the central nervous system. Neurol Res Int (2012) 2012:460825. doi:10.1155/2012/460825
14. Sinnecker T, Dorr J, Pfueller CF, Harms L, Ruprecht K, Jarius S, et al. Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology (2012) 79:708-14. doi:10.1212/WNL.0b013e3182648bc8
15. Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 14:1157-74. doi:10.1177/1352458508096878
16. Wuerfel J, Sinnecker T, Ringelstein EB, Jarius S, Schwindt W, Niendorf T, et al. Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis. Mult Scler (2012) 18:1592-9. doi:10.1177/1352458512441270
17. Lummel N, Boeckh-Behrens T, Schoepf V, Burke M, Bruckmann H, Linn J. Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis? Neuroradiology (2011) 53:311-7. doi:10.1007/s00234-010-0736-z
18. Theodoridou A, Settas L. Demyelination in rheumatic diseases. Postgrad Med J (2008) 84:127-32. doi:10.1136/jnnp.2005.075861
19. Reichenbach JR, Venkatesan R, Yablonskiy DA, Thompson MR, Lai S, Haacke EM. Theory and application of static field inhomogeneity effects in gradient-echo imaging. J Magn Reson Imaging (1997) 7:266-79. doi:10.1002/jmri.1880070203
20. Ogawa S, Lee TM, Nayak AS, Glynn P. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med (1990) 14:68-78. doi:10.1002/mrm.1910140108
21. Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology (1997) 204:272-7.
22. Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng YCN Susceptibility-weighted imaging: technical aspects and clinical applications, part1. AJNR Am J Neuroradiol (2009) 30:19-30. doi:10.3174/ajnr.A1400
23. Xu Y, Haacke EM. The role of voxel aspect ratio in determining apparent vascular phase behavior in susceptibility weighted imaging. Magn Reson Imaging (2006) 24:155-60. doi:10.1016/j.mri.2005.10.030
24. Reichenbach JR, Barth M, Haacke EM, Klarhofer M, Kaiser WA, Moser E. High-resolution MR venography at 3.0 Tesla. J Comput Assist Tomogr (2000) 24:949-57. doi:10.1097/00004728-200011000-00023
25. Grabner G, Dal-Bianco A, Schernthaner M, Vass K, Lassmann H, Trattnig S. Analysis of multiple sclerosis lesions using a fusion of 3.0T FLAIR and 7.0T SWI phase: FLAIR SWI. J Magn Reson Imaging (2011) 33:543-9. doi:10.1002/jmri.22452
26. Sati P, George IC, Shea CD, Gaitan MI, Reich DS. Flair*: a combined MR contrast technique for visualizing white matter lesions and parenchymal veins. Radiology (2012) 265:926-32. doi:10.1148/radiol.12120208
27. Ge Y, Zohrabian VM, Grossman RI. Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis. Arch Neurol (2008) 65:812-6. doi:10.1001/archneur.65.6.812
28. Tallantyre EC, Brookes MJ, Dixon JE, Morgan PS, Evangelou N, Morris PG. Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology (2008) 70:2076-8. doi:10.1212/01.wnl.0000313377.49555.2e
29. Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ, Evangelou N, et al. A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest Radiol (2009) 44:491-4. doi:10.1097/RLI.0b013e3181b4c144
30. Tallantyre EC, Dixon JE, Donaldson I, Owens T, Morgan PS, Morris PG, et al. Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions. Neurology (2011) 76:534-9. doi:10.1212/WNL.0b013e31820b7630
31. Kau T, Taschwer M, Deutschmann H, Schonfelder M, Weber JR, Hausegger KA. The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis? Eur Radiol (2013) 23:1956-62. doi:10.1007/s00330-013-2791-4
32. Quinn MP, Gati JS, Klassen LM, Lin AW, Bird JR, Leung SE, et al. Comparison of multiecho postprocessing schemes for SWI with use of linear and nonlinear mask functions. AJNR Am J Neuroradiol (2013) 34. doi:10.3174/ajnr.A3584
33. Dixon JE, Simpson A, Mistry N, Evangelou N, Morris PG. Optimisation of T2(*)-weighted MRI for the detection of small veins in multiple sclerosis at 3t and 7t. Eur J Radiol (2013) 82:719-27. doi:10.1016/j.ejrad.2011.09.023